Skip to content
Lower risk Medical device recall · FDA · Published February 21, 2023

Biosense Webster Carto Vizigo Sheath Recall: Incorrect Labeling Hazard

Biosense Webster recalls specific Carto Vizigo Bi-Directional Guiding Sheaths due to incorrect labeling on carton versus inner pouch. This mismatch may cause confusion during medical procedures. Affected units include lot #00002137 with UDI 1084683:5016253.

🇺🇸 FDA recall #Z-1319-2023Medical deviceBiosense Webster ›
Take action

Contact the company

Recalling firmBiosense Webster, Inc.31 Technology Dr Ste 200 · Irvine, CA 92618-2302
✎ GovInfoNow plain-language explainer

Biosense Webster is recalling certain Carto Vizigo Bi-Directional Guiding Sheaths because the product name, lot number, and code on the outer carton label don't match the inner pouch label. This labeling error could lead to confusion during medical procedures, potentially affecting patient safety. Read more at govinfonow.com/recall/58860-biosense-webster-carto-vizigo-sheath-recall-incorrect-labeling-hazard.

Source Summary by GovInfoNow · govinfonow.com/recall/58860-biosense-webster-carto-vizigo-sheath-recall-incorrect-labeling-hazard · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1319-2023

Cite this page

“Biosense Webster Carto Vizigo Sheath Recall: Incorrect Labeling Hazard.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/58860-biosense-webster-carto-vizigo-sheath-recall-incorrect-labeling-hazard. Based on FDA recall #Z-1319-2023 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1319-2023%22&limit=1).

Biosense Webster, Inc. recalled the Carto Vizigo Bi-Directional Guiding Sheath due to incorrect labeling where carton labels do not match inner pouches, according to the FDA on Feb. 21, 2023.

How to tell if you have it

  • Brand: Biosense Webster
  • Product: Carto Vizigo Bi-Directional Guiding Sheath, 8.5F(Small), REF D-1385-01-S, RX CE 2797, Sterile
  • Lot #: 00002137
  • UDI (GTIN): 10846835016253

The hazard

The product name, lot number and product code on the carton label for Bi-Directional Guiding Sheaths does not match the inner label pouch.

Context

GovInfoNow's records show Biosense Webster, Inc. has 7 other recalls on record since June 14, 2017. Other recent recalls of similar products include Covidien Shiley Tracheostomy Tube Recall (April 15, 2026), Fresenius Medical Care Bicarby Dialysate Recall (May 7, 2026) and Omnicell i.v.Station Label Stock Recall (March 25, 2026).

How to tell if you have this one

Check for the lot number 00002137 and UDI (GTIN) 10846835016253 on the carton label. The product is a sterile, 8.5F (Small) Bi-Directional Guiding Sheath with reference code D-1385-01-S and RX CE 2797.

  • Brand
    Biosense Webster
  • Category
    Medical device
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    Worldwide distribution - US Nationwide distribution including the states of AK, AL, AR, AZ, CA, CO, CT, FL, GA, IA, IL, IN, KS, KY, MA, MD, MI, MN, MO, MS, MT, NC, NJ, NV, NY, OH, OK, PA, SC, SD, TN, TX, UT, VA, WI. The country of Japan.
Recall numberProduct, codes & lotsQuantity
Z-1319-2023Biosense Webster Carto Vizigo Bi-Directional Guiding Sheath, 8.5F(Small), REF D-1385-01-S, RX CE 2797, Sterile; Lot # 00002137; UDI (GTIN) : 10846835016253277
Z-1320-2023Biosense Webster Carto Vizigo Bi-Directional Guiding Sheath, 8.5F(Medium), REF D-1385-02-S, RX CE 2797, Sterile; Lot # 50000224; UDI (GTIN) : 10846835016277316 units
Based on the official FDA remedy

What to do — step by step

  1. Check Labels

    Verify the carton label matches the inner pouch label for product name, lot number, and code.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 35 states.

Alaska: named in the noticeAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: nationwideWAIdaho: nationwideIDMontana: named in the noticeMTNorth Dakota: nationwideNDMinnesota: named in the noticeMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: nationwideRIMassachusetts: named in the noticeMAOregon: nationwideORNevada: named in the noticeNVWyoming: nationwideWYSouth Dakota: named in the noticeSDIowa: named in the noticeIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: named in the noticeCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: named in the noticeCONebraska: nationwideNEMissouri: named in the noticeMOKentucky: named in the noticeKYWest Virginia: nationwideWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: nationwideDEArizona: named in the noticeAZNew Mexico: nationwideNMKansas: named in the noticeKSArkansas: named in the noticeARTennessee: named in the noticeTNNorth Carolina: named in the noticeNCSouth Carolina: named in the noticeSCDistrict of Columbia: nationwideDCOklahoma: named in the noticeOKLouisiana: nationwideLAMississippi: named in the noticeMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: nationwideHITexas: named in the noticeTXFlorida: named in the noticeFL

FDA distribution: “Worldwide distribution - US Nationwide distribution including the states of AK, AL, AR, AZ, CA, CO, CT, FL, GA, IA, IL, IN, KS, KY, MA, MD, MI, MN, MO, MS, MT, NC, NJ, NV, NY, OH, OK, PA, SC, SD, TN, TX, UT, VA, WI. The country of Japan.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Iowa, Kansas, Kentucky, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Wisconsin.

Recall timeline

FDA published this recall 50 days after the firm started it.

1. Firm started the recall: Feb 21, 202312. FDA classified it Class II: Mar 31, 202323. Published in FDA’s Enforcement Report: Apr 12, 202332023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1319-2023 (February 21, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1319-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA